Peer Reviewed Journals

Kelly BD, Miller N, Healy NA, Walsh K, Kerin MJ (2012) 'A review of expression profiling of circulating microRNAs in men with prostate cancer'. Bju International, . [DOI] [Details]

Pilarski, R,Patel, DA,Weitzel, J,McVeigh, T,Dorairaj, JJ,Heneghan, HM,Miller, N,Weidhaas, JB,Kerin, MJ,McKenna, M,Wu, XF,Hildebrandt, M,Zelterman, D,Sand, S,Shulman, LP (2012) 'The KRAS-Variant Is Associated with Risk of Developing Double Primary Breast and Ovarian Cancer'. Plos One, 7 (5). [DOI] [Details]

Nugent, M,Miller, N,Kerin, MJ (2012) 'Circulating miR-34a levels are reduced in colorectal cancer'. Journal Of Surgical Oncology, 106 :947-952. [DOI] [Details]

Glynn, RW,Miller, N,Mahon, S,Kerin, MJ (2012) 'Expression levels of HER2/neu and those of collocated genes at 17q12-21, in breast cancer'. Oncol Rep, 28 (1):365-369. [DOI] [Details]

Lambrechts D, Truong T, Justenhoven C, Humphreys MK, Wang J, Hopper JL, Dite GS, Apicella C, Southey MC, Schmidt MK, Broeks A, Cornelissen S, van Hien R, Sawyer E, Tomlinson I, Kerin M, Miller N et al. (2012) '11q13 is a susceptibility locus for hormone receptor positive breast cancer'. Human Mutation, 33 (7):1123-1132. [DOI] [Details]

Healy NA, Heneghan HM, Miller N, Osborne CK, Schiff R, Kerin MJ (2012) 'Systemic mirnas as potential biomarkers for malignancy'. International Journal Of Cancer, 131 (10):2215-2222. [DOI] [Details]

Waters PS, McDermott AM, Wall D, Heneghan HM, Miller N, Newell J, Kerin MJ and Dwyer RM. (2012) 'Relationship between circulating and tissue microRNAs in a murine model of breast cancer'. Plos One, 7 (11). [Details]

Kheirelseid EA, Miller N, Chang KH, Curran C, Hennessy E, Sheehan M, Newell J, Lemetre C, Balls G, Kerin MJ (2012) 'miRNA expressions in rectal cancer as predictors of response to neoadjuvant chemoradiation therapy'. International Journal Of Colorectal Disease, . [DOI] [Details]

Kheirelseid EA, Miller N, Chang KH, Newell J, Kerin MJ (2012) 'mRNA/miRNA correlations in colorectal cancer: novel mechanisms in cancer initiation and progression'. International Journal Of Colorectal Disease, . [DOI] [Details]

Hein R, Maranian M, Hopper JL, Kapuscinski MK, Southey MC, Park DJ, Schmidt MK, Broeks A, Hogervorst FB, Bueno-de-Mesquit HB, Muir KR, Lophatananon A, Rattanamongkongul S, Puttawibul P, Fasching PA, Hein A, Ekici AB, Beckmann MW, Fletcher O, Johnson N, dos Santos Silva I, Peto J, Sawyer E, Tomlinson I, Kerin M, Miller N, Marmee F, Schneeweiss A, Sohn C, Burwinkel B, Guénel P, Cordina-Duverger E, Menegaux F, Truong T, Bojesen SE, Nordestgaard BG, Flyger H, Milne RL, Perez JI, Zamora MP, Benítez J, Anton-Culver H, Ziogas A, Bernstein L, Clarke CA, Brenner H, Müller H, Arndt V, Stegmaier C, Rahman N, Seal S, Turnbull C, Renwick A, Meindl A, Schott S, Bartram CR, Schmutzler RK, Brauch H, Hamann U, Ko YD; GENICA Network, Wang-Gohrke S, Dörk T, Schürmann P, Karstens JH, Hillemanns P, Nevanlinna H, Heikkinen T, Aittomäki K, Blomqvist C, Bogdanova NV, Zalutsky IV, Antonenkova NN, Bermisheva M, Prokovieva D, Farahtdinova A, Khusnutdinova E, Lindblom A, Margolin S, Mannermaa A, Kataja V, Kosma VM, Hartikainen J, Chen X, Beesley J; Kconfab Investigators; AOCS Group, Lambrechts D, Zhao H, Neven P, Wildiers H, Nickels S, Flesch-Janys D, Radice P, Peterlongo P, Manoukian S, Barile M, Couch FJ, Olson JE, Wang X, Fredericksen Z, Giles GG, Baglietto L, McLean CA, Severi G, Offit K, Robson M, Gaudet MM, Vijai J, Alnæs GG, Kristensen V, Børresen-Dale AL, John EM, Miron A, Winqvist R, Pylkäs K, Jukkola-Vuorinen A, Grip M, Andrulis IL, Knight JA, Glendon G, Mulligan AM, Figueroa JD, García-Closas M, Lissowska J, Sherman ME, Hooning M, Martens JW, Seynaeve C, Collée M, Hall P, Humpreys K, Czene K, Liu J, Cox A, Brock IW, Cross SS, Reed MW, Ahmed S, Ghoussaini M, Pharoah PD, Kang D, Yoo KY, Noh DY, Jakubowska A, Jaworska K, Durda K, Złowocka E, Sangrajrang S, Gaborieau V, Brennan P, McKay J, Shen CY, Yu JC, Hsu HM, Hou MF, Orr N, Schoemaker M, Ashworth A, Swerdlow A, Trentham-Dietz A, Newcomb PA, Titus L, Egan KM, Chenevix-Trench G, Antoniou AC, Humphreys MK, Morrison J, Chang-Claude J, Easton DF, Dunning AM. (2012) 'Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC)'. Plos One, 7 (8). [Details]

Kheirelseid, EAH,Jumustafa, H,Miller, N,Curran, C,Sweeney, K,Malone, C,McLaughlin, R,Newell, J,Kerin, MJ (2011) 'Bilateral breast cancer: analysis of incidence, outcome, survival and disease characteristics'. Breast Cancer Research And Treatment, 126 :131-140. [DOI] [Details]

Heneghan, HM,Miller, N,McAnena, OJ,O'Brien, T,Kerin, MJ (2011) 'Differential miRNA Expression in Omental Adipose Tissue and in the Circulation of Obese Patients Identifies Novel Metabolic Biomarkers'. Journal Of Clinical Endocrinology & Metabolism, 96 :846-850. [DOI] [Details]

Paranjape, T,Heneghan, H,Lindner, R,Keane, FK,Hoffman, A,Hollestelle, A,Dorairaj, J,Geyda, K,Pelletier, C,Nallur, S,Martens, JWM,Hooning, MJ,Kerin, M,Zelterman, D,Zhu, Y,Tuck, D,Harris, L,Miller, N,Slack, F,Weidhaas, J (2011) 'A 3 '-untranslated region KRAS variant and triple-negative breast cancer: a case-control and genetic analysis'. Lancet Oncology, 12 (4):377-386. [DOI] [Details]

Glynn, RW,Mahon, S,Curran, C,Callagy, G,Miller, N,Kerin, MJ (2011) 'TOP2A Amplification in the Absence of That of HER-2/neu: Toward Individualization of Chemotherapeutic Practice in Breast Cancer'. Oncologist, 16 (7):949-955. [DOI] [Details]

Chang, KH,Miller, N,Kheirelseid, EAH,Ingoldsby, H,Hennessy, E,Curran, CE,Curran, S,Smith, MJ,Regan, M,McAnena, OJ,Kerin, MJ (2011) 'MicroRNA-21 and PDCD4 expression in colorectal cancer'. European Journal Of Cancer, 37 :597-603. [DOI] [Details]

Heneghan HM, Miller N, Kerin MJ (2011) 'Circulating microRNAs: promising breast cancer Biomarkers'. Breast Cancer Research, 13 (1). [DOI] [Details]

McDermott AM, Heneghan HM, Miller N, Kerin MJ (2011) 'The therapeutic potential of microRNAs: disease modulators and drug targets'. Pharmaceutical research, 28 (12):3016-3029. [DOI] [Details]

Nugent M, Miller N, Kerin MJ (2011) 'MicroRNAs in colorectal cancer: function, dysregulation and potential as novel biomarkers'. Eur J Surg Oncol, 37 (8):649-654. [DOI] [Details]

Milne RL, Goode EL, García-Closas M, Couch FJ, Severi G, Hein R, Fredericksen Z, Malats N, Zamora MP, Arias Pérez JI, Benítez J, Dörk T, Schürmann P, Karstens JH, Hillemanns P, Cox A, Brock IW, Elliot G, Cross SS, Seal S, Turnbull C, Renwick A, Rahman N, Shen CY, Yu JC, Huang CS, Hou MF, Nordestgaard BG, Bojesen SE, Lanng C, Grenaker Alnæs G...Sawyer E, Tomlinson I, Kerin M, Miller N et al. (2011) 'Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer'. Cancer Epidemiology Biomarkers & Prevention, 20 (10):2222-2231. [Details]

Chang, KH,Miller, N,Kheirelseid, EAH,Lemetre, C,Ball, GR,Smith, MJ,Regan, M,McAnena, OJ,Kerin, MJ (2011) 'MicroRNA signature analysis in colorectal cancer: identification of expression profiles in stage II tumors associated with aggressive disease'. International Journal Of Colorectal Disease, 26 (11):1415-1422. [DOI] [Details]

Yang XR, Chang-Claude J, Goode EL, Couch FJ, Nevanlinna H, Milne RL, Gaudet M, Schmidt MK, Broeks A, Cox A, Fasching PA, Hein R, Spurdle AB, Blows F, Driver K, Flesch-Janys D, Heinz J, Sinn P, Vrieling A...Sawyer EJ, Tomlinson IP, Jones A, Kerin M, Miller N, McInerney N et al. (2011) 'Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies'. Journal Of The National Cancer Institute, 103 (3):250-263. [DOI] [Details]

Glynn RW, Miller N, Kerin MJ (2010) '17q12-21 - The pursuit of targeted therapy in breast cancer'. Cancer Treat Rev, 36 (3):224-229. [Details]

Kheirelseid EA, Jumustafa H, Miller N, Curran C, Sweeney K, Malone C, McLaughlin R, Newell J, Kerin MJ. (2010) 'Authorship trends in the surgical literature'. Br J Surg, 97 (8):1304-1308. [Details]

Heneghan HM, Miller N, Kerin MJ. (2010) 'Circulating miRNA signatures: promising prognostic tools for cancer'. J Clin Oncol, 28 (29):573-574. [Details]

Heneghan HM, Miller N, Kerin MJ (2010) 'Systemic microRNAs: novel biomarkers for colorectal and other cancers?'. Gut, 59 (7):1002-101. [DOI] [Details]

Heneghan, HM,Miller, N,Kerin, MJ (2010) 'MiRNAs as biomarkers and therapeutic targets in cancer'. Curr Opin Pharmacol, 10 (5):543-550. [DOI] [Details]

Heneghan, HM,Miller, N,Kerin, MJ (2010) 'Role of microRNAs in obesity and the metabolic syndrome'. Obes Rev, 11 (5):354-361. [DOI] [Details]

Heneghan, HM,Miller, N,Kelly, R,Newell, J,Kerin, MJ (2010) 'Systemic miRNA-195 Differentiates Breast Cancer from Other Malignancies and Is a Potential Biomarker for Detecting Noninvasive and Early Stage Disease'. Oncologist, 15 (7):673-682. [DOI] [Details]

Martin, FT,Dwyer, RM,Kelly, J,Khan, S,Murphy, JM,Curran, C,Miller, N,Hennessy, E,Dockery, P,Barry, FP,O'Brien, T,Kerin, MJ (2010) 'Potential role of mesenchymal stem cells (MSCs) in the breast tumour microenvironment: stimulation of epithelial to mesenchymal transition (EMT)'. Breast Cancer Research And Treatment, 124 :317-326. [DOI] [Details]

Glynn, RW,Miller, N,Whelan, MC,Kerin, MJ (2010) 'Topoisomerase 2 Alpha and the Case for Individualized Breast Cancer Therapy'. Annals Of Surgical Oncology, 17 (5):1392-1397. [DOI] [Details]

Heneghan, HM,Miller, N,Lowery, AJ,Sweeney, KJ,Newell, J,Kerin, MJ (2010) 'Circulating microRNAs as Novel Minimally Invasive Biomarkers for Breast Cancer'. Ann Surg, 251 :499-505. [DOI] [Details]

Colleran, G,McInerney, N,Rowan, A,Barclay, E,Jones, AM,Curran, C,Miller, N,Kerin, M,Tomlinson, I,Sawyer, E (2010) 'The TGFBR1*6A/9A polymorphism is not associated with differential risk of breast cancer'. Breast Cancer Research And Treatment, 119 (2):437-442. [DOI] [Details]

Kheirelseid, EAH,Chang, KH,Newell, J,Kerin, MJ,Miller, N (2010) 'Identification of endogenous control genes for normalisation of real-time quantitative PCR data in colorectal cancer'. BMC Molecular Biology, 11 . [DOI] [Details]

Chang, KH,Mestdagh, P,Vandesompele, J,Kerin, MJ,Miller, N (2010) 'MicroRNA expression profiling to identify and validate reference genes for relative quantification in colorectal cancer'. BMC Cancer, 10 . [DOI] [Details]

McInerney, NM,Miller, N,Rowan, A,Colleran, G,Barclay, E,Curran, C,Kerin, MJ,Tomlinson, IP,Sawyer, E (2010) 'Evaluation of variants in the CHEK2, BRIP1 and PALB2 genes in an Irish breast cancer cohort'. Breast Cancer Research And Treatment, 121 :203-210. [DOI] [Details]

Lowery, AJ, Miller, N, Dwyer, RM, Kerin, MJ (2010) 'Dysregulated miR-183 inhibits migration in breast cancer cells'. BMC Cancer, 10 . [DOI] [Details]

Mcinerney N, Colleran G, Rowan A, Walther A, Barclay E, Spain S, Jones AM, Tuohy S, Curran C, Miller N, Kerin M, Tomlinson I, Sawyer E. (2009) 'Low penetrance breast cancer predisposition SNPs are site specific'. Breast Cancer Res Treat, 117 (1):151-159. [DOI] [Details]

Heneghan HM, Miller N, Lowery AJ, Sweeney KJ, Kerin MJ (2009) 'MicroRNAs as Novel Biomarkers for Breast Cancer'. Journal of oncology, 2009 . [DOI] [Details]

Lowery, AJ,Miller, N,Devaney, A,McNeill, RE,Davoren, PA,Lemetre, C,Benes, V,Schmidt, S,Blake, J,Ball, G,Kerin, MJ (2009) 'MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancer'. Breast Cancer Research, 11 (3). [DOI] [Details]

McCafferty, M. P. J.,McNeill, R. E.,Miller, N.,Kerin, M. J. (2009) 'Interactions between the estrogen receptor, its cofactors and microRNAs in breast cancer'. Breast Cancer Research and Treatment, 116 (33):425-432. [Details]

Lowery, A. J., Miller, N., McNeill, R. E. & Kerin, M. J. (2008) 'MicroRNAs as Prognostic Indicators and Therapeutic Targets: Potential Effect on Breast Cancer Management'. Clinical Cancer Research, 14 (2):360-365. [Details]

Bretschneider, N,Brand, H,Miller, N,Lowery, AJ,Kerin, MJ,Gannon, F,Denger, S (2008) 'Estrogen induces repression of the breast cancer and salivary gland expression gene in an estrogen receptor alpha-dependent manner'. Cancer Research, 68 :106-114. [DOI] [Details]

Davoren, PA,McNeill, RE,Lowery, AJ,Kerin, MJ,Miller, N (2008) 'Identification of suitable endogenous control genes for microRNA gene expression analysis in human breast cancer'. BMC Molecular Biology, 9 . [DOI] [Details]

Manning, A. T., Garvin, J. T., Shahbazi, R. I., Miller, N., McNeill, R. E. & Kerin, M. J. (2007) 'Molecular profiling techniques and bioinformatics in cancer research'. European Journal Of Surgical Oncology, 33 (3):255-265. [Details]

McNeill, RE,Miller, N,Kerin, MJ (2007) 'Evaluation and validation of candidate endogenous control genes for real-time quantitative PCR studies of breast cancer'. BMC Molecular Biology, 8 . [DOI] [Details]

Miller, N,McCann, AH,O'Connell, D,Pedersen, IS,Spiers, V,Gorey, T,Dervan, PA (1997) 'The MAS proto-oncogene is imprinted in human breast tissue'. Genomics, 46 :509-512. [Details]

McCann, AH,Miller, N,OMeara, A,Pedersen, I,Keogh, K,Gorey, T,Dervan, PA (1996) 'Biallelic expression of the IGF2 gene in human breast disease'. Human Molecular Genetics, 5 :1123-1127. [Details]

 

Conference Publications

McCafferty, M. P. J.,McNeill, R. E.,Miller, N.,Kerin, M. J. (2009) Relationships between estrogen receptor co-regulators and intrinsic subtypes in breast cancer San Antonio Breast Cancer Symposium 2008 [Details]

Mahon, S.,Miller, N.,Curran, C.,Dockery, P.,Callagy, G.,Kerin, M. J. (2009) Cancer Research The microvasculature of invasive ductal breast carcinoma: a sterological approach [Details]

 

Abstract

Helen, E,Healy, N,Gorman, A,Miller, N,Kerin, MJ (2011) Expression of genes related to neurotrophin signalling in breast cancer - in search of novel therapeutic techniques. Abstract [Details]

Kheirelseid, EAH,Miller, N,Chang, KH,McAnena, OJ,Regan, M,Kerin, MJ (2010) Clinical applications of molecular profiling of colorectal cancer. Abstract [Details]

Chang, K,Miller, N,Kheirelseid, E,Ball, G,Smith, MJ,Regan, M,McAnena, OJ,Kerin, MJ (2010) ANN Analysis to Identify MicroRNA Expression Patterns in Colorectal Cancer. Abstract [Details]

Chang, KH,Miller, N,Kerin, MJ (2009) MicroRNA expression profile in stage II colorectal cancer. Abstract [Details]

McInerney, N,Miller, N,Rowan, A,Colleran, G,Curran, C,Sawyer, E,Tomlinson, IP,Kerin, MJ (2009) Evaluation of proposed candidate genetic variants in a west of Ireland breast cancer cohort. Abstract [Details]

Mahon, S,Miller, N,Curran, C,Dockery, P,Callagy, G,Kerin, MJ (2009) The microvasculature of invasive ductal breast carcinoma: a sterological approach. Abstract [Details]

Mc Inerney, NM,Colleran, G,Walther, A,Rowan, A,Spain, S,Jones, AM,Tuohy, S,Barclay, E,Curran, C,Miller, N,Kerin, MJ,Tomlinson, I,Eli, S (2009) Low penetrance breast cancer predisposition SNPs are site specific. Abstract [Details]

Heneghan, HM,Miller, N,Kerin, MJ (2009) Increased systemic microRNAs in breast cancer correlate with tumour microRNA profile and clinicopathologic characteristics. Abstract [Details]

Kheirelseid, EAH,Jumastapha, H,Miller, N,Curran, C,Sweeney, KJ,Newell, J,Kerin, MJ (2009) Bilateral Breast Cancer: Analysis of Incidence, Characteristics and Outcome of the Disease. Abstract [Details]

Heneghan, HM,Miller, N,Newell, J,Kerin, MJ (2009) Systemic MiRNA Levels as Novel Breast Cancer Biomarkers. Abstract [Details]

Mc Inerney, NM,Miller, N,Rowan, A,Colleran, G,Curran, C,Ian, T,Eli, S,Michael, KJ (2009) Evaluation of variants in BRIP1, PALB2 and CHEK2 in a west of Ireland breast cancer cohort. Abstract [Details]

Aj, L,Miller, N,Re, M,Mj, K (2007) MicroRNA expression in primary breast tumors. Abstract [Details]

Aj, L,Miller, N,Mj, K (2007) Expression of the putative breast cancer gene breast cancer and salivary gland expression; relationship with microRNA 154*and estrogen receptor status. Abstract [Details]

Lowery, AJ,Miller, N,McNeill, RE,Kerin, MJ (2007) Micro-RNA expression profiling in primary breast tumours. Abstract [Details]

Lowery, AJ,Miller, N,Kerin, MJ (2007) Expression of the putative breast cancer gene BASE; relationship with microRNA 154* and estrogen receptor status. Abstract [Details]

McNeill, RE,Miller, N,Kerin, MJ (2007) The identification and validation of novel endogenous control genes for the analysis of gene expression data in breast cancer tissues by real-time quantitative PCR. Abstract [Details]

Colleran, GC,Rowan, A,Miller, N,Sawyer, E,Curran, C,Kerin, M,Tomlinson, I (2007) The CHEK2*1100deIC variant: present in the west of Ireland breast cancer population. Abstract [Details]

                                                                                                     

Reviews

Healy, NA,Heneghan, HM,Miller, N,Osborne, CK,Schiff, R,Kerin, MJ (2012) Systemic mirnas as potential biomarkers for malignancy. Reviews [DOI] [Details]

McDermott, AM,Heneghan, HM,Miller, N,Kerin, MJ (2011) The Therapeutic Potential of MicroRNAs: Disease Modulators and Drug Targets. Reviews [DOI] [Details]

Nugent, M,Miller, N,Kerin, MJ (2011) MicroRNAs in colorectal cancer: Function, dysregulation and potential as novel biomarkers. Reviews [DOI] [Details]

Glynn, RW,Miller, N,Kerin, MJ (2010) 17q12-21-The pursuit of targeted therapy in breast cancer. Reviews [DOI] [Details]

McCafferty, MPJ,McNeill, RE,Miller, N,Kerin, MJ (2009) Interactions between the estrogen receptor, its cofactors and microRNAs in breast cancer. Reviews [DOI] [Details]

Lowery, AJ,Miller, N,McNeill, RE,Kerin, MJ (2008) MicroRNAs as prognostic indicators and therapeutic targets: Potential effect on breast cancer management. Reviews [DOI] [Details]

Manning, AT,Garvin, JT,Shahbazi, RI,Miller, N,McNeill, RE,Kerin, MJ (2007) Molecular profiling techniques and bioinformatics in cancer research. Reviews [DOI] [Details]

                                 

Letter

Weidhaas, J,Slack, F,Miller, N,Harris, L,Tuck, D,Zhu, Y,Zelterman, D,Kerin, M,Paranjape, T,Heneghan, H,Lindner, R,Keane, F,Dorairaj, J,Geyda, K,Pelletier, C,Nallur, S (2011) Association between KRAS rs61764370 and triple-negative breast cancer-a false positive? reply. Letter [Details]

Heneghan, HM,Miller, N,Kerin, MJ (2011) Circulating microRNAs: promising breast cancer biomarkers. Letter [DOI] [Details]

Heneghan, HM,Miller, N,Kerin, MJ (2010) Systemic microRNAs: novel biomarkers for colorectal and other cancers?. Letter [DOI] [Details]

Heneghan, HM,Miller, N,Kerin, MJ (2010) Circulating miRNA Signatures: Promising Prognostic Tools for Cancer. Letter [DOI] [Details]

Meeting

Healy, NA,Schiff, R,Miller, N,Osborne, CK,Kerin, MJ (2012) The role of miRNAs in tamoxifen resistance in breast cancer. Meeting [Details]

McDermott, AM,Miller, N,Sweeney, KJ,Ball, G,Kerin, MJ (2012) Identification and validation of novel microRNA oncologic biomarkers of Luminal-A breast cancer. Meeting [Details]

Walsh, JW,McDermott, AM,Miller, N,Sweeney, KJ,Kerin, MJ (2012) Circulating miR-497 as a novel minimally invasive biomarker for breast cancer. Meeting [Details]

Kelly, BD,Miller, N,Durkan, GC,Sweeney, KJ,Rogers, E,Walsh, K,Kerin, MJ (2012) Circulating MicroRNA signatures: A novel minimally invasive biomarker for prostate cancer. Meeting [Details]

McDermott, A,Miller, N,Sweeney, K,Ball, G,Kerin, M (2012) Identification and validation of novel circulating microRNA biomarkers for Luminal A breast cancer. Meeting [Details]

McDermott, AM,Walsh, J,Heneghan, HM,Wall, D,Miller, N,Kerin, MJ (2012) Differential Expression Of miR-15 Family Members in Breast Cancer. Meeting [Details]

Kelly, BD,Miller, N,Sweeney, KJ,Durkan, GC,Rogers, E,Walsh, K,Kerin, MJ (2012) Circulating miR-141 as a diagnostic biomarker for prostate cancer and for monitoring response to treatment. Meeting [Details]

Kheirelseid, EAH,Miller, N,Chang, KH,McAnena, OJ,Regan, M,Kerin, MJ (2011) Molecular profiling of colorectal cancer: Does it apply clinically?. Meeting [Details]

Healy, NA,Heneghan, HM,Lowery, AJ,Miller, N,Kerin, MJ (2011) Expression profiling of circulating miRNAs in breast cancer. Meeting [Details]

Kelly, BD,Miller, N,Durkan, GC,Sweeney, KJ,Rogers, E,Walsh, K,Kerin, MJ (2011) Circulating miRNAs as blood based markers for prostate cancer. Meeting [Details]

Dorairaj, JJ,Irwin, R,Wall, D,Cody, N,Miller, N,Sweeney, KJ,Green, A,Kerin, MJ (2011) Clinicopathological variables of BRCA 1 and 2 gene mutations in the west of Ireland population. Meeting [Details]

Nugent, M,Kheirelseid, EAH,Heneghan, HM,Chang, KH,Miller, N,Kerin, MJ (2010) CIRCULATING microRNAs IN COLORECTAL CANCER. Meeting [Details]

Heneghan, HM,Miller, N,Paranjape, T,Slack, FJ,Weidhaas, JB,Kerin, MJ (2010) A SNP IN LET-7 MIRNA BINDING SITE IN THE KRAS ONCOGENE INCREASES RISK OF TRIPLE NEGATIVE BREAST CANCER. Meeting [Details]

Glynn, RW,Miller, N,Mahon, S,Doolin, O,Curran, C,Kerin, MJ (2010) 17Q12-21: HER2/NEU, TOP2A, AND THE CASE FOR INDIVIDUALISED THERAPY IN BREAST CANCER. Meeting [Details]

Kelly, RJ,Heneghan, HM,Miller, N,Kerin, MJ (2010) EXPRESSION OF MICRORNAS AND THEIR PREDICTED PROTEIN TARGETS IN THE CIRCULATION OF BREAST CANCER PATIENTS: NOVEL BIOMARKERS FOR BREAST CANCER. Meeting [Details]

Kheirelseid, EAH,Miller, N,Chang, KH,McAnena, OJ,Regan, M,Kerin, MJ (2010) Liver-intestinal cadherin (CDH17) is downregulated in colorectal cancer and associated with tumour progression. Meeting [Details]

Healy, NA,Heneghan, HM,Lowery, AJ,Miller, N,Kerin, MJ (2010) DYSREGULATED CANCER-SPECIFIC MiRNAs IN THE CIRCULATION OF BREAST CANCER PATIENTS. Meeting [DOI] [Details]

Heneghan, HM,Miller, N,Paranjape, T,Slack, FJ,Weidhaas, JB,Kerin, MJ (2010) A KRAS MICRORNA BINDING SITE VARIANT IS A GENETIC MARKER OF RISK FOR TRIPLE NEGATIVE BREAST CANCER. Meeting [DOI] [Details]

Glynn, RW,Miller, N,Mahon, S,Doolin, O,Curran, C,Kerin, MJ (2010) Identification of potential therapeutic targets at the HER2/NEU amplicon. Meeting [Details]

Kheirelseid, EAH,Jumastapha, H,Miller, N,Curran, C,Sweeney, K,Kerin, MJ (2010) Bilateral breast cancer: do synchronous and metachronous tumours represent different disease entities?. Meeting [Details]

Kheirelseid, EAH,Miller, N,Chang, KH,McAnena, OJ,Regan, M,Kerin, MJ (2010) MOLECULAR PROFILING OF COLORECTAL CANCER. Meeting [Details]

Heneghan, HM,Miller, N,Kelly, R,Nugent, M,Kerin, MJ (2010) A SYSTEMIC MIRNA SIGNATURE PREDICTIVE OF EARLY BREAST CANCER. Meeting [Details]

Healy, NA,Heneghan, HM,Miller, N,Kerin, MJ (2010) EXPRESSION PROFILING OF SYSTEMICALLY EXPRESSED BREAST CANCER-SPECIFIC miRNAS. Meeting [Details]

Glynn, RW,Miller, N,Iglesias, EA,Doolin, O,Newell, J,Kerin, MJ (2009) Characterisation of 17q12-21-Identification of Novel Therapeutic Targets. Meeting [Details]

Garvin, JT,McNeill, RE,Hennessy, E,Miller, N,Kerin, MJ (2007) MMP9 IS ASSOCIATED WITH POOR OUTCOME IN BREAST CANCER WHILE MMP9 AND MMP11 EXPRESSION ARE INCREASED IN OESTROGEN RECEPTOR POSITIVE BREAST CANCER. Meeting [Details]

Garvin, JT,McNeill, RE,Hennessy, E,Miller, N,Kerin, MJ (2007) GATA3 AND BAG1 OVER-EXPRESSION ARE ASSOCIATED WITH GOOD PROGNOSIS IN NODE NEGATIVE BREAST CANCER. Meeting [Details]

Garvin, JT,McNeill, RE,Hennessy, E,Miller, N,Kerin, MJ (2007) Gene expression profiling of axillary node negative tumour tissues using microarrays to inform prognosis in breast cancer. Meeting [Details]

Davoren, PA,Miller, N,McNeill, R,Kerin, MJ (2007) Characterisation of specific micro-RNA expression profiles in fresh frozen human breast tissue. Meeting [Details]

Manning, AT,Garvin, JT,McNeill, RE,Miller, N,Hennessy, E,Kerin, MJ (2006) Cathepsin K gene expression and breast cancer metastases. Meeting [Details]

Miller, N,McCann, A,O'Connell, D,Pedersen, IS,Spiers, V,Gorey, T,Dervan, PA (1998) Mono-allelic expression of the Mas proto-oncogene in human breast tissue. Meeting [Details]